Correction

Published on 01 Feb 2024

Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

in Vaccines and Molecular Therapeutics

Franciane Mouradian Emidio Teixeira
Luana de Mendonça Oliveira
Anna Cláudia Calvielli Castelo Branco
Ricardo Wesley Alberca
Emanuella Sarmento Alho de Sousa
Bruno Henrique de Sousa Leite
Wenny Camilla dos Santos Adan
Alberto José da Silva Duarte
Roberto Dias Lins
Maria Notomi Sato

Frontiers in Immunology

doi 10.3389/fimmu.2024.1376059

578 views

Original Research

Published on 31 Jan 2024

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

in Vaccines and Molecular Therapeutics

Jennifer Serwanga
Violet Ankunda
Joseph Ssebwana Katende
Claire Baine
Gerald Kevin Oluka
Geoffrey Odoch
Hellen Nantambi
Susan Mugaba
Angella Namuyanja
Ivan Ssali

Frontiers in Immunology

doi 10.3389/fimmu.2024.1348905

1,773 views
1 citation

Original Research

Published on 30 Jan 2024

Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species

in Vaccines and Molecular Therapeutics

Michiel M. Harmsen
Bart Ackerschott
Hans de Smit

Frontiers in Immunology

doi 10.3389/fimmu.2024.1346328

4,010 views
2 citations

Original Research

Published on 30 Jan 2024

Selection of vaccine-candidate peptides from Mycobacterium avium subsp. paratuberculosis by in silico prediction, in vitro T-cell line proliferation, and in vivo immunogenicity

in Vaccines and Molecular Therapeutics

Kari Lybeck
Stig Tollefsen
Heidi Mikkelsen
Siri Kulberg Sjurseth
Claus Lundegaard
Claus Aagaard
Ingrid Olsen
Gregers Jungersen

Frontiers in Immunology

doi 10.3389/fimmu.2024.1297955

3,437 views

Systematic Review

Published on 30 Jan 2024

CAR Immunotherapy for the treatment of infectious diseases: a systematic review

in Vaccines and Molecular Therapeutics

Elena Morte-Romea
Cecilia Pesini
Galadriel Pellejero-Sagastizábal
Santiago Letona-Giménez
Luis Martínez-Lostao
Silvia Loscos Aranda
Carla Toyas
Sergio Redrado
Elena Dolader-Ballesteros
Maykel Arias

Frontiers in Immunology

doi 10.3389/fimmu.2024.1289303

5,780 views
2 citations

Brief Research Report

Published on 29 Jan 2024

Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

in Vaccines and Molecular Therapeutics

Annkristin Heine
Niels A. W. Lemmermann
Chrystel Flores
Janine Becker-Gotot
Natalio Garbi
Peter Brossart
Christian Kurts

Frontiers in Immunology

doi 10.3389/fimmu.2024.1338499

1,788 views

Original Research

Published on 26 Jan 2024

Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys

in Vaccines and Molecular Therapeutics

Marit Middeldorp
Janneke W. Duijster
Jan van de Kassteele
Fiona R.M. van der Klis
Hester E. de Melker

Frontiers in Immunology

doi 10.3389/fimmu.2024.1327770

1,430 views

Original Research

Published on 26 Jan 2024

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

in Vaccines and Molecular Therapeutics

Valentina Laquintana
Carla Mottini
Francesco Marchesi
Benedetta Marcozzi
Irene Terrenato
Eleonora Sperandio
Luisa de Latouliere
Francesca Carrieri
Fulvia Pimpinelli
Martina Pontone

Frontiers in Immunology

doi 10.3389/fimmu.2023.1221587

1,952 views

Review

Published on 24 Jan 2024

Clinical research on RSV prevention in children and pregnant women: progress and perspectives

in Vaccines and Molecular Therapeutics

Xuejia Gong
Erdan Luo
Li Fan
Wanggang Zhang
Yan Yang
Yuhua Du
Xiao Yang
Shasha Xing

Frontiers in Immunology

doi 10.3389/fimmu.2023.1329426

4,147 views
3 citations

Original Research

Published on 23 Jan 2024

A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus

in Vaccines and Molecular Therapeutics

Yating Wang
Shijia Liu
Boshuo Li
Xinyao Sun
Qi Pan
Yuxin Zheng
Jia Liu
Yongqiang Zhao
Jingyu Wang
Liming Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1336239

3,858 views
1 citation

Review

Published on 23 Jan 2024

Nanobodies: a promising approach to treatment of viral diseases

in Vaccines and Molecular Therapeutics

Vitória Meneghetti Minatel
Carlos Roberto Prudencio
Benedito Barraviera
Rui Seabra Ferreira

Frontiers in Immunology

doi 10.3389/fimmu.2023.1303353

5,419 views
5 citations

Review

Published on 22 Jan 2024

The current landscape of the antimicrobial peptide melittin and its therapeutic potential

in Vaccines and Molecular Therapeutics

Hai-Qian Zhang
Chengbiao Sun
Na Xu
Wensen Liu

Frontiers in Immunology

doi 10.3389/fimmu.2024.1326033

5,165 views
13 citations

Original Research

Published on 22 Jan 2024

Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

in Vaccines and Molecular Therapeutics

Swayam Prakash
Nisha R. Dhanushkodi
Latifa Zayou
Izabela Coimbra Ibraim
Afshana Quadiri
Pierre Gregoire Coulon
Delia F. Tifrea
Berfin Suzer
Amin Mohammed Shaik
Amruth Chilukuri

Frontiers in Immunology

doi 10.3389/fimmu.2024.1328905

4,684 views
9 citations

Review

Published on 19 Jan 2024

The uncharted territory of host-pathogen interaction in tuberculosis

in Vaccines and Molecular Therapeutics

Antara Ghoshal
Akanksha Verma
Ashima Bhaskar
Ved Prakash Dwivedi

Frontiers in Immunology

doi 10.3389/fimmu.2024.1339467

3,881 views
4 citations

Original Research

Published on 19 Jan 2024

Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

in Vaccines and Molecular Therapeutics

Franciane Mouradian Emidio Teixeira
Luana de Mendonça Oliveira
Anna Cláudia Calvielli Castelo Branco
Ricardo Wesley Alberca
Emanuella Sarmento Alho de Sousa
Bruno Henrique de Sousa Leite
Wenny Camilla dos Santos Adan
Alberto José da Silva Duarte
Roberto Dias Lins
Maria Notomi Sato

Frontiers in Immunology

doi 10.3389/fimmu.2024.1307546

2,474 views

Original Research

Published on 17 Jan 2024

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination

in Vaccines and Molecular Therapeutics

Murat Gainullin
Lorenzo Federico
Julie Røkke Osen
Viktoriia Chaban
Hassen Kared
Amin Alirezaylavasani
Fridtjof Lund-Johansen
Gull Wildendahl
Jon-Aksel Jacobsen
Hina Sarwar Anjum

Frontiers in Immunology

doi 10.3389/fimmu.2023.1235210

2,085 views

Navigation group

Articles

Corrigendum: Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

Sustained S-IgG and S-IgA antibodies to Moderna’s mRNA-1273 vaccine in a Sub-Saharan African cohort suggests need for booster timing reconsiderations

Serum immunoglobulin or albumin binding single-domain antibodies that enable tailored half-life extension of biologics in multiple animal species

Selection of vaccine-candidate peptides from Mycobacterium avium subsp. paratuberculosis by in silico prediction, in vitro T-cell line proliferation, and in vivo immunogenicity

CAR Immunotherapy for the treatment of infectious diseases: a systematic review

Rapid protection against viral infections by chemokine-accelerated post-exposure vaccination

Immune response following a two-dose schedule of bivalent HPV vaccination among girls and boys

Dynamics of humoral and cellular response to three doses of anti-SARS-CoV-2 BNT162b2 vaccine in patients with hematological malignancies and older subjects

Clinical research on RSV prevention in children and pregnant women: progress and perspectives

A novel CpG ODN compound adjuvant enhances immune response to spike subunit vaccines of porcine epidemic diarrhea virus

Nanobodies: a promising approach to treatment of viral diseases

The current landscape of the antimicrobial peptide melittin and its therapeutic potential

Cross-protection induced by highly conserved human B, CD4+, and CD8+ T-cell epitopes-based vaccine against severe infection, disease, and death caused by multiple SARS-CoV-2 variants of concern

The uncharted territory of host-pathogen interaction in tuberculosis

Enhanced immunogenicity and protective efficacy in mice following a Zika DNA vaccine designed by modulation of membrane-anchoring regions and its association to adjuvants

People who use drugs show no increase in pre-existing T-cell cross-reactivity toward SARS-CoV-2 but develop a normal polyfunctional T-cell response after standard mRNA vaccination